What is the recommended management for herpes zoster?

Management of Herpes Zoster

Critical Note on Evidence Provided

The evidence provided primarily addresses genital herpes simplex virus (HSV) infection, NOT herpes zoster (shingles caused by varicella-zoster virus). I will answer based on the limited relevant evidence available and general medical knowledge specific to herpes zoster management.

Antiviral Therapy

Initiate systemic antiviral therapy within 72 hours of rash onset to reduce disease severity, duration, and risk of postherpetic neuralgia (PHN). 1, 2, 3

First-Line Antiviral Options (all equally effective):

• Acyclovir 800 mg orally 5 times daily for 7-10 days 2, 3
• Valacyclovir 1000 mg orally 3 times daily for 7 days 2
• Famciclovir 500 mg orally 3 times daily for 7 days 2
• Brivudin (where available) 125 mg once daily for 7 days - offers simplified dosing with once-daily administration 3

Urgent Indications for Antiviral Therapy:

• All patients ≥50 years of age 3
• Herpes zoster ophthalmicus or any head/neck involvement 3
• Immunocompromised patients (including HIV-infected, transplant recipients, cancer patients, those on immunosuppressive therapy) 3
• Severe disease on trunk or extremities 3
• Patients with severe atopic dermatitis or eczema 3

Relative Indications:

• Patients <50 years with uncomplicated trunk or extremity involvement have only relative indications for treatment 3

Pain Management

Adequate analgesia is the most important therapeutic goal and should be initiated immediately alongside antiviral therapy. 3

Pain Management Algorithm:

• Appropriately dosed analgesics combined with neuroactive agents (e.g., amitriptyline) 3
• For established PHN, use in decreasing order of recommendation:
  • Gabapentin or pregabalin (first-line) 4
  • Tricyclic antidepressants (amitriptyline, nortriptyline, desipramine) 4
  • Topical lidocaine or capsaicin for localized pain 4
  • Opioid analgesics (tramadol, morphine, oxycodone, methadone) as last resort 4

Early Preventive Pain Management:

• For patients at high risk of PHN, consider early initiation of gabapentin or amitriptyline at onset of herpes zoster 4
• Corticosteroids may shorten acute zoster pain duration but do NOT prevent PHN development 3

Special Populations

Immunocompromised Patients:

• May require higher antiviral doses and longer treatment courses 3
• Consider intravenous acyclovir 10 mg/kg every 8 hours for severe disease, disseminated infection, or CNS involvement 2
• Refer to pain specialist early if pain is severe 3

Severe Disease Requiring Hospitalization:

• IV acyclovir 10 mg/kg every 8 hours until clinical improvement 2
• Indications include disseminated infection, encephalitis, pneumonitis, hepatitis, or other systemic complications 2

Diagnostic Approach

Diagnosis is primarily clinical based on characteristic dermatomal vesicular rash 3

Laboratory confirmation when needed:

• PCR (gold standard) 3
• Direct VZV identification in cell cultures 3
• IgM and IgA anti-VZV antibodies may help in immunocompromised patients 3

Prevention

Vaccination is the most effective preventive strategy:

• Recombinant zoster vaccine (RZV/Shingrix) is recommended for adults ≥50 years as a 2-dose series 5
• RZV can be used in immunocompromised patients ≥18 years 5
• Live attenuated vaccine (ZVL/Zostavax) is contraindicated in immunocompromised individuals 5

Common Pitfalls to Avoid

• Do NOT use topical antivirals - they are substantially less effective than systemic therapy 3
• Do NOT delay treatment waiting for laboratory confirmation in typical presentations 3
• Do NOT withhold antivirals beyond 72 hours if new lesions are still forming or in high-risk patients 1
• Do NOT undertreat pain - aggressive pain management prevents chronic PHN 3
• Do NOT use corticosteroids with expectation of preventing PHN 3